| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Human |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-SLAMF6 (24-332) is suitable for use in Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3. |
| Purification: |
Affinity purification |
| Dilution Range: |
WB 1:100-1:500 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
SLAMF6 |
| Gene ID: |
114836 |
| Uniprot ID: |
SLAF6_HUMAN |
| Immunogen Region: |
24-332 |
| Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 24-332 of human SLAMF6 (NP_001171643.1). |
| Immunogen Sequence: |
SLTPLMVNGILGESVTLPLE FPAGEKVNFITWLFNETSLA FIVPHETKSPEIHVTNPKQG KRLNFTQSYSLQLSNLKMED TGSYRAQISTKTSAKLSSYT LRILRQLRNIQVTNHSQLFQ NMTCELHLTCSVEDADDNVS FRWEALGNTLSSQPNLTVSW DPRISSEQDYTCIAENAVSN LSFSVSAQKLCE |
| Tissue Specificity | Expressed by all (resting and activated) natural killer cells (NK), T- and B-lymphocytes. Increased surface expression on T-cells of systemic lupus erythematosus (SLE) patients. |
| Post Translational Modifications | Phosphorylation in NK cells upon engagment by SLAMF6-expressing target cells is leading to receptor activation. |
| Function | Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo- or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response. Activities are controlled by presence or absence of small cytoplasmic adapter proteins, SH2D1A/SAP and/or SH2D1B/EAT-2. Triggers cytolytic activity only in natural killer cells (NK) expressing high surface densities of natural cytotoxicity receptors. Positive signaling in NK cells implicates phosphorylation of VAV1. NK cell activation seems to depend on SH2D1B and not on SH2D1A. In conjunction with SLAMF1 controls the transition between positive selection and the subsequent expansion and differentiation of the thymocytic natural killer T (NKT) cell lineage. Promotes T-cell differentiation into a helper T-cell Th17 phenotype leading to increased IL-17 secretion.the costimulatory activity requires SH2D1A. Promotes recruitment of RORC to the IL-17 promoter. In conjunction with SLAMF1 and CD84/SLAMF5 may be a negative regulator of the humoral immune response. In the absence of SH2D1A/SAP can transmit negative signals to CD4(+) T-cells and NKT cells. Negatively regulates germinal center formation by inhibiting T-cell:B-cell adhesion.the function probably implicates increased association with PTPN6/SHP-1 via ITSMs in absence of SH2D1A/SAP. However, reported to be involved in maintaining B-cell tolerance in germinal centers and in preventing autoimmunity. |
| Protein Name | Slam Family Member 6Activating Nk ReceptorNk-T-B-AntigenNtb-ACd Antigen Cd352 |
| Database Links | Reactome: R-HSA-198933 |
| Cellular Localisation | Cell MembraneSingle-Pass Type I Membrane Protein |
| Alternative Antibody Names | Anti-Slam Family Member 6 antibodyAnti-Activating Nk Receptor antibodyAnti-Nk-T-B-Antigen antibodyAnti-Ntb-A antibodyAnti-Cd Antigen Cd352 antibodyAnti-SLAMF6 antibodyAnti-KALI antibodyAnti-UNQ6123 antibodyAnti-PRO20080 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
